miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma

microRNAs aberrant behavior in heptocellular carcinoma (HCC) plays a major role in HCC pathogenesis. miR-615-5p expression has never been evaluated in HCC. We showed that miR-615-5p was preferentially expressed in HCC, cirrhotic liver tissues and HCC cell lines, but undetected in normal livers. Forc...

Full description

Saved in:
Bibliographic Details
Main Authors: El Tayebi, Hend M. (Author) , Breuhahn, Kai (Author)
Format: Article (Journal)
Language:English
Published: 20 July 2012
In: FEBS letters
Year: 2012, Volume: 586, Issue: 19, Pages: 3309-3316
ISSN:1873-3468
DOI:10.1016/j.febslet.2012.06.054
Online Access:Verlag, Volltext: https://doi.org/10.1016/j.febslet.2012.06.054
Verlag, Volltext: https://febs.onlinelibrary.wiley.com/doi/abs/10.1016/j.febslet.2012.06.054
Get full text
Author Notes:H.M. El Tayebi, K.A. Hosny, G. Esmat, K. Breuhahn, Ahmed Ihab Abdelaziz
Description
Summary:microRNAs aberrant behavior in heptocellular carcinoma (HCC) plays a major role in HCC pathogenesis. miR-615-5p expression has never been evaluated in HCC. We showed that miR-615-5p was preferentially expressed in HCC, cirrhotic liver tissues and HCC cell lines, but undetected in normal livers. Forced miR-615-5p expression in HCC cell lines led to significant decrease in cell growth and migration. In-silico predication revealed insulin-like growth factor-II (IGF-II) as a potential downstream target for miR-615-5p. Forcing the expression of miR-615-5p showed downregulation of IGF-II mRNA, as well as inhibition of the luciferase activity in a luciferase reporter vector harboring the IGF-II-3′UTR target sequence. miR-615-5p acts as tumor-suppressor in HCC through targeting IGF-II.
Item Description:Gesehen am 27.06.2019
Physical Description:Online Resource
ISSN:1873-3468
DOI:10.1016/j.febslet.2012.06.054